THE AUSTRALIAN CENTRE FOR TRANSLATIONAL BREAST CANCER RESEARCH: FROM DISCOVERY TO BETTER HEALTH OUTCOMES
Grant number: 1040978 | Funding period: 2012 - 2017
TransBCR will implement a collaborative multidisciplinary research program to help fast track the clinical translation of promising laboratory discoveries in breast cancer. To overcome existing roadblocks, we will carry out early phase clinical trials of novel anti-breast cancer drugs linked to suitable diagnostic tests that help select the right therapy for individual cancer patients. Our goal is to help inform the swift delivery of cost-effective personalised medicine in breast cancer.
Related publications (3)
Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer
Emma Nolan, Peter Savas, Antonia N Policheni, Phillip K Darcy, Francois Vaillant, Christopher P Mintoff, Sathana Dushyanthen, Mariam Mansour, Jia-Min B Pang, Stephen B Fox, Charles M Perou, Jane E Visvader, Daniel HD Gray, Sherene Loi, Geoffrey J Lindeman